Article
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2020
Krämer Pauline, Talhouk Aline, Brett Mary Anne, Chiu Derek S, Cairns Evan S, Scheunhage Daniëlla A, Hammond Rory F L, Farnell David, Nazeran Tayyebeh M, Grube Marcel, Xia Zhouchunyang, Senz Janine, Leung Samuel, Feil Lukas, Pasternak Jana, Dixon Katherine, Hartkopf Andreas, Krämer Bernhard, Brucker Sara, Heitz Florian, du Bois Andreas, Harter Philipp, Kommoss Felix K F, Sinn Hans-Peter, Heublein Sabine, Kommoss Friedrich, Vollert Hans-Walter, Manchanda Ranjit, de Kroon Cornelis D, Nijman Hans W, de Bruyn Marco, Thompson Emily F, Bashashati Ali, McAlpine Jessica N, Singh Naveena, Tinker Anna V, Staebler Annette, Bosse Tjalling, Kommoss Stefan, Köbel Martin, Anglesio Michael S
Abstract excerpt
PURPOSE: Endometrioid ovarian carcinoma (ENOC) is generally associated with a more favorable prognosis compared with other ovarian carcinomas. Nonetheless, current patient treatment continues to follow a "one-size-fits-all" approach. Even though tumor staging offers stratification, personalized treatments remain elusive. As ENOC shares many clinical and molecular features with its endometrial counterpart, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.